These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9629831)

  • 21. Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization, and future intentions.
    Mercer SL; Goel V; Levy IG; Ashbury FD; Iverson DC; Iscoe NA
    Can J Public Health; 1997; 88(5):327-32. PubMed ID: 9401168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of distance learning on clinical management of LUTS in primary care: a randomised trial.
    Wolters R; Wensing M; Klomp M; Lagro-Jansen T; Weel Cv; Grol R
    Patient Educ Couns; 2005 Nov; 59(2):212-8. PubMed ID: 16257627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians.
    Austin OJ; Valente S; Hasse LA; Kues JR
    Arch Fam Med; 1997; 6(5):453-8. PubMed ID: 9305688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing.
    Farrell MH; Murphy MA; Schneider CE
    Eff Clin Pract; 2002; 5(3):120-9. PubMed ID: 12088291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
    Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
    J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intention to test for prostate cancer.
    Berglund G; Nilsson S; Nordin K
    Eur J Cancer; 2005 May; 41(7):990-7. PubMed ID: 15862747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Australian general practitioners' views and use of tests to detect early prostate cancer.
    Ward J; Young J; Sladden M
    Aust N Z J Public Health; 1998; 22(3 Suppl):374-80. PubMed ID: 9629825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
    Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
    Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
    Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
    Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and detection of prostate cancer: a pilot intervention in a resource--poor South African community.
    Matshela RF; Maree JE; van Belkum C
    Cancer Nurs; 2014; 37(3):189-97. PubMed ID: 23632472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An exploration of screening practices for prostate cancer and the associated community expenditure.
    Perkins JJ; Sanson-Fisher RW; Clarke SJ; Youman P
    Br J Urol; 1998 Oct; 82(4):524-9. PubMed ID: 9806181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting.
    Naslund MJ; Gilsenan AW; Midkiff KD; Bown A; Wolford ET; Wang J
    Int J Clin Pract; 2007 Sep; 61(9):1437-45. PubMed ID: 17686091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.
    Walz J; Suardi N; Hutterer GC; Perrotte P; Gallina A; Bénard F; Valiquette L; McCormack M; Graefen M; Montorsi F; Karakiewicz PI
    J Endourol; 2008 Feb; 22(2):369-76. PubMed ID: 18294044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006.
    Ross LE; Taylor YJ; Richardson LC; Howard DL
    J Natl Med Assoc; 2009 Apr; 101(4):316-24. PubMed ID: 19397221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship among age, prostate-specific antigen, and prostate volume in men with lower urinary tract symptoms (LUTS) and in different groups of men with and without benign and malignant prostate diseases.
    Di Silverio F; Sciarra A; D'Eramo G; Casale P; Loreto A; Seccareccia F
    Prostate; 1998 Jun; 36(1):1-7. PubMed ID: 9650909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer awareness and screening practice among Kenyan men.
    Erena AN; Shen G; Lei P
    Eur J Cancer Prev; 2020 May; 29(3):252-258. PubMed ID: 32243332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
    Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ
    BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).
    Rosen R; Altwein J; Boyle P; Kirby RS; Lukacs B; Meuleman E; O'Leary MP; Puppo P; Robertson C; Giuliano F
    Eur Urol; 2003 Dec; 44(6):637-49. PubMed ID: 14644114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.